Alkermes seeks to support investigator research designed and conducted by independent physicians and scientists. Alkermes has supported more than 40 clinical trials since the beginning of the IIT program in 2008. Alkermes can provide VIVITROL®, ARISTADA® and/or placebo to the IIT programs it supports. In addition, there may be limited financial support available. In general, the research we support is based in the U.S. with experienced researchers who have an established history of successfully receiving independent funding.
Areas of Interest
Substance Use Disorders
IIT applications are reviewed by a cross functional team of medical and scientific staff to consider patient safety, operational feasibility, scientific merit, and alignment with Alkermes research goals and needs. Applications can be submitted in one of two ways:
Please be aware that Alkermes cannot guarantee support for IIT program applications and all decisions regarding such support will be made at Alkermes’ sole discretion.
|Application Submission Cut-Off Date||Quarterly Meeting Review|